[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Procept Biorobotics Corp (PRCT)

Procept Biorobotics Corp (PRCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,046,171
  • Shares Outstanding, K 56,919
  • Annual Sales, $ 308,050 K
  • Annual Income, $ -95,570 K
  • EBIT $ -109 M
  • EBITDA $ -103 M
  • 60-Month Beta 0.89
  • Price/Sales 3.44
  • Price/Cash Flow N/A
  • Price/Book 3.05

Options Overview Details

View History
  • Implied Volatility 93.20% (+1.60%)
  • Historical Volatility 61.02%
  • IV Percentile 94%
  • IV Rank 70.78%
  • IV High 112.02% on 07/24/26
  • IV Low 47.62% on 08/28/25
  • Expected Move (DTE 16) 2.74 (14.97%)
  • Put/Call Vol Ratio 0.61
  • Today's Volume 2,535
  • Volume Avg (30-Day) 381
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 9,228
  • Open Int (30-Day) 11,809
  • Expected Range 15.54 to 21.02

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.46
  • Number of Estimates 4
  • High Estimate $-0.36
  • Low Estimate $-0.51
  • Prior Year $-0.35
  • Growth Rate Est. (year over year) -31.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.67 +9.69%
on 07/24/26
21.88 -16.43%
on 07/06/26
-2.75 (-13.08%)
since 07/02/26
3-Month
16.67 +9.69%
on 07/24/26
29.74 -38.53%
on 06/09/26
-6.55 (-26.38%)
since 05/04/26
52-Week
16.67 +9.69%
on 07/24/26
49.90 -63.36%
on 08/05/25
-31.32 (-63.15%)
since 08/04/25

Most Recent Stories

More News
PROCEPT BioRobotics Securities Fraud Class Action Lawsuit Filed; September 22, 2026, Lead Plaintiff Deadline

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

PRCT : 18.28 (-0.54%)
Kaplan Fox Notifies PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors of a Securities Class Action Deadline on September 22, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BAC : 62.90 (+0.67%)
PRCT : 18.28 (-0.54%)
PROCEPT BioRobotics Corporation Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit

Did you buy PRCT common stock between February 28, 2024 and February 25, 2026?

PRCT : 18.28 (-0.54%)
PROCEPT BioRobotics Class Action Lawsuit: Investors Face September 22, 2026, Deadline

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

PRCT : 18.28 (-0.54%)
PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results

SAN JOSE, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...

PRCT : 18.28 (-0.54%)
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , Aug. 4, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP  announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against...

PRCT : 18.28 (-0.54%)
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , Aug. 4, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith  announces that investors with substantial losses have opportunity to lead the securities fraud class action...

PRCT : 18.28 (-0.54%)
PRCT INVESTOR ALERT: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN FRANCISCO , Aug. 4, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation  (NASDAQ: PRCT) that a securities class action has been filed...

PRCT : 18.28 (-0.54%)
Lost Money on PROCEPT BioRobotics Corporation (PRCT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

NEW YORK , Aug. 4, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of  PROCEPT BioRobotics Corporation (NASDAQ: PRCT).

PRCT : 18.28 (-0.54%)
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation...

PRCT : 18.28 (-0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use...

See More

Key Turning Points

3rd Resistance Point 19.60
2nd Resistance Point 19.05
1st Resistance Point 18.66
Last Price 18.28
1st Support Level 17.72
2nd Support Level 17.17
3rd Support Level 16.79

See More

52-Week High 49.90
Fibonacci 61.8% 37.20
Fibonacci 50% 33.28
Fibonacci 38.2% 29.36
Last Price 18.28
52-Week Low 16.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.